Literature Review
Decision making about breast cancer has been the subject of research in various contexts. Several studies have explored the experience of women newly diagnosed Decision-Making Process of Women Carrying a BRCA1 or BRCA2 Mutation Who Have Chosen Prophylactic Mastectomy Megan McQuirter, MSc(A), Luisa Luciani Castiglia, BScN, CON(C), Carmen G. Loiselle, N, PhD, and Nora Wong, MS Purpose/Objectives: To explore the decision-making process of women with a BRCA1 or BRCA2 gene mutation who have chosen to undergo prophylactic mastectomy.
Design: Cross-sectional, qualitative, descriptive design.
Setting: Participants were recruited from an outpatient cancer prevention center in the oncology and medical genetics departments of a large university-affiliated hospital in Montreal, Quebec, Canada.
Sample: 10 women carrying a BRCA1 or BRCA2 mutation; 8 previously had had a prophylactic mastectomy and 2 were scheduled for surgery at the time of study.
Methods: Semistructured, in-depth interviews were conducted. Field notes were written and audiotapes were transcribed verbatim. The textual data were coded and analyzed.
Main Research Variables: Decision-making process for prophylactic mastectomy.
Findings: Two broad findings emerged. First, several intrapersonal and contextual factors interacted throughout the process to move women either closer to choosing a prophylactic mastectomy or further from the decision. Second, all women reported experiencing a "pivotal point," an emotionally charged event when the decision to have a prophylactic mastectomy became definitive. Pivotal points for patients included either receiving a positive result for a genetic mutation or a breast cancer diagnosis for herself or a family member in the context of positive mutation status.
Conclusions: Decision making about prophylactic mastectomy was an affective and intuitive process incorporating contexts and their relations rather than a rational, straightforward process of weighing pros and cons. with breast cancer who were making surgical treatment decisions. Preference for involvement in decision making varied from active participation to deferring to the expertise of physicians (Hack, Degner, Watson, & Sinha, 2006;  
